Influence of Human Leukocyte Antigen (HLA) Alleles and Killer Cell Immunoglobulin-Like Receptors (KIR) Types on Heparin-Induced Thrombocytopenia (HIT)
Author
Karnes, Jason HShaffer, Christian M
Cronin, Robert
Bastarache, Lisa
Gaudieri, Silvana
James, Ian
Pavlos, Rebecca
Steiner, Heidi E
Mosley, Jonathan D
Mallal, Simon
Denny, Joshua C
Phillips, Elizabeth J
Roden, Dan M
Affiliation
Univ Arizona, Coll Pharm, Dept Pharm Practice & SciIssue Date
2017-09-01Keywords
HLAelectronic health records
heparin-induced thrombocytopenia
immunogenetics
killer cell immunoglobulin-like receptor (KIR)
pharmacogenomics
Metadata
Show full item recordPublisher
WILEYCitation
Karnes, J. H., Shaffer, C. M., Cronin, R. , Bastarache, L. , Gaudieri, S. , James, I. , Pavlos, R. , Steiner, H. E., Mosley, J. D., Mallal, S. , Denny, J. C., Phillips, E. J. and Roden, D. M. (2017), Influence of Human Leukocyte Antigen (HLA) Alleles and Killer Cell Immunoglobulin‐Like Receptors (KIR) Types on Heparin‐Induced Thrombocytopenia (HIT). Pharmacotherapy, 37: 1164-1171. doi:10.1002/phar.1983Journal
PHARMACOTHERAPYRights
© 2017 Pharmacotherapy Publications, Inc.Collection Information
This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.Abstract
Heparin-induced thrombocytopenia (HIT) is an unpredictable, life-threatening, immune-mediated reaction to heparin. Variation in human leukocyte antigen (HLA) genes is now used to prevent immune-mediated adverse drug reactions. Combinations of HLA alleles and killer cell immunoglobulin-like receptors (KIR) are associated with multiple autoimmune diseases and infections. The objective of this study is to evaluate the association of HLA alleles and KIR types, alone or in the presence of different HLA ligands, with HIT. HIT cases and heparin-exposed controls were identified in BioVU, an electronic health record coupled to a DNA biobank. HLA sequencing and KIR type imputation using Illumina OMNI-Quad data were performed. Odds ratios for HLA alleles and KIR types and HLA*KIR interactions using conditional logistic regressions were determined in the overall population and by race/ethnicity. Analysis was restricted to KIR types and HLA alleles with a frequency greater than 0.01. The p values for HLA and KIR association were corrected by using a false discovery rate q<0.05 and HLA*KIR interactions were considered significant at p<0.05. Sixty-five HIT cases and 350 matched controls were identified. No statistical differences in baseline characteristics were observed between cases and controls. The HLA-DRB3*01:01 allele was significantly associated with HIT in the overall population (odds ratio 2.81 [1.57-5.02], p=2.1×10-4 , q=0.02) and in individuals with European ancestry, independent of other alleles. No KIR types were associated with HIT, although a significant interaction was observed between KIR2DS5 and the HLA-C1 KIR binding group (p=0.03). The HLA-DRB3*01:01 allele was identified as a potential risk factor for HIT. This class II HLA gene and allele represent biologically plausible candidates for influencing HIT pathogenesis. We found limited evidence of the role of KIR types in HIT pathogenesis. Replication and further study of the HLA-DRB3*01:01 association is necessary.Note
12 month embargo; published online: 8 July 2017ISSN
1875-9114PubMed ID
28688202Version
Final accepted manuscriptSponsors
Vanderbilt CTSA grant from NCATS/NIH [ULTR000445, UL1TR000445]; National Institutes of Health grants from NIGMS/OD [RC2GM092618]; NHGRI/NIGMS [U01HG004603, U19HL065962]; VUMC Clinical Pharmacology Training grant [T32 GM07569]; American Heart Association [16SDG29090005, 15POST22660017]; ACCP Research Institute Futures Grants Award from the American College of Clinical PharmacyAdditional Links
https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/phar.1983ae974a485f413a2113503eed53cd6c53
10.1002/phar.1983
Scopus Count
Collections
Related articles
- Killer cell immunoglobulin-like receptor and human leukocyte antigen gene profiles in a cohort of HIV-infected Mexican Mestizos.
- Authors: Garrido-Rodríguez D, Ávila-Ríos S, García-Morales C, Valenzuela-Ponce H, Ormsby C, Reyes-Gopar H, Fernandez-Lopez JC, Reyes-Terán G
- Issue date: 2016 Oct
- The Influence of HLA and KIR Genes on Malignant Melanoma Development and Progression.
- Authors: Kandilarova SM, Paschen A, Mihaylova A, Ivanova M, Schadendorf D, Naumova E
- Issue date: 2016 Dec
- A genome-wide association study of heparin-induced thrombocytopenia using an electronic medical record.
- Authors: Karnes JH, Cronin RM, Rollin J, Teumer A, Pouplard C, Shaffer CM, Blanquicett C, Bowton EA, Cowan JD, Mosley JD, Van Driest SL, Weeke PE, Wells QS, Bakchoul T, Denny JC, Greinacher A, Gruel Y, Roden DM
- Issue date: 2015 Apr
- Epistatic interactions between killer immunoglobulin-like receptors and human leukocyte antigen ligands are associated with ankylosing spondylitis.
- Authors: Hanson AL, International Genetics of Ankylosing Spondylitis Consortium, Vukcevic D, Leslie S, Harris J, Lê Cao KA, Kenna TJ, Brown MA
- Issue date: 2020 Aug
- Analysis of Killer Cell Immunoglobulin-Like Receptor Genes and Their HLA Ligands in Inflammatory Bowel Diseases.
- Authors: Beigmohammadi F, Mahmoudi M, Karami J, Ahmadzadeh N, Ebrahimi-Daryani N, Rezaei N
- Issue date: 2020